Work

Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study

Year: 2011

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdq632

Authors: C. Bokemeyer, I. Bondarenko, J.T. Hartmann, F. de Braud, G. Schuch, A. Zubel, I. Celik, M. Schlichting, P. Koralewski

Institutions: University Medical Center Hamburg-Eppendorf, Dnipro State Medical University, Universitätsklinikum Tübingen, University of Tübingen, European Institute of Oncology, Merck KGaA, Darmstadt (Germany)

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Merck KGaA

OpenAlex ID: W2139168548

FWCI: 38.58

Cites: 31

Cited by: 775

Related to: 10